Evidence map›Paper›PMID 22442679›Full record

Trial reportPloS one2012

Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients.

Lourdes Garrido-Sánchez, Eduardo García-Fuentes, Diego Fernández-García, Xavier Escoté, Juan Alcaide, Pablo Perez-Martinez, Joan Vendrell, Francisco J Tinahones

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Zinc.Advances in food and nutrition research · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Lourdes Garrido-SánchezCIBERDEM, Hospital Universitari Joan XXIII, Pere Virgili Institute, Tarragona, Spain. lourgarrido@gmail.com
Eduardo García-Fuentes
Diego Fernández-García
Xavier Escoté
Juan Alcaide
Pablo Perez-Martinez
Joan Vendrell
Francisco J Tinahones
Institut d'Investigació Sanitària Pere Virgili · ESCentro de Investigación Biomédica en Red · ESFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Universitario Reina Sofía · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveZinc-α(2) glycoprotein (ZAG) stimulates lipid loss by adipocytes and may be involved in the regulation of adipose tissue metabolism. However, to date no studies have been made in the most extreme of obesity. The aims of this study are to analyze ZAG expression levels in adipose tissue from morbidly obese patients, and their relationship with lipogenic and lipolytic genes and with insulin resistance (IR).

methodsmRNA expression levels of PPARγ, IRS-1, IRS-2, lipogenic and lipolytic genes and ZAG were quantified in visceral (VAT) and subcutaneous adipose tissue (SAT) of 25 nondiabetic morbidly obese patients, 11 with low IR and 14 with high IR. Plasma ZAG was also analyzed.

resultsThe morbidly obese patients with low IR had a higher VAT ZAG expression as compared with the patients with high IR (p = 0.023). In the patients with low IR, the VAT ZAG expression was greater than that in SAT (p = 0.009). ZAG expression correlated between SAT and VAT (r = 0.709, p<0.001). VAT ZAG expression was mainly predicted by insulin, HOMA-IR, plasma adiponectin and expression of adiponectin and ACSS2. SAT ZAG expression was only predicted by expression of ATGL.

conclusionsZAG could be involved in modulating lipid metabolism in adipose tissue and is associated with insulin resistance. These findings suggest that ZAG may be a useful target in obesity and related disorders, such as diabetes.

Indexed as

Gene Expression RegulationInsulin ResistanceLipolysisAdultArabidopsis ProteinsHumansInsulin Receptor Substrate ProteinsIntra-Abdominal FatIntramolecular TransferasesMaleMiddle AgedObesity, MorbidPPAR gammaSeminal Plasma ProteinsSubcutaneous FatZn-Alpha-2-GlycoproteinArabidopsis ProteinsInsulin Receptor Substrate ProteinsIntramolecular TransferasesIRS1 protein, humanmarneral synthase, ArabidopsisPPAR gammaSeminal Plasma ProteinsZn-Alpha-2-Glycoprotein

Identifiers

PMID22442679
PMCPMC3307730
OpenAlexW2066780282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.